We found that IHC with a two-antibody (MSH6 and PMS2) panel would detect all 16 (100%) Lynch syndrome cases in the PETALS study, and on the basis of the assumption that it would halve the cost of IHC testing, it would also result in cost saving, costing £1200 per Lynch syndrome case identified. This evidence concerns the gene PMS2 and Lynch syndrome.